BRIEF-Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026
Reuters
Dec 17, 2025
BRIEF-Tenax Therapeutics Level Trial On Track To Complete Enrollment In H1 2026
Dec 17 (Reuters) - Tenax Therapeutics Inc TENX.O:
TENAX THERAPEUTICS INC - LEVEL TRIAL ON TRACK TO COMPLETE ENROLLMENT IN FIRST HALF OF 2026; TOPLINE DATA EXPECTED IN SECOND HALF OF 2026
Source text: ID:nGNX6cChdx
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.